ArticleInternational journal of women's health2026
Chylous Lymphocyst Following Retroperitoneal Lymphadenectomy: A Case Report and Review of Treatment.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chylous lymphocyst or lymphocele following pelvic and para-aortic lymphadenectomy is rare. Clinically, patients usually present with abdominal distension or abdominal pain. The milky appearance of the cystic fluid reflects its high triglyceride content. Although specific guidelines for managing chylous lymphocyst are limited, the approaches used for chylous ascites can generally be applied. More than 70% of patients respond to conservative treatment, which includes a modified diet consisting of high protein, fat restriction, and medium-chain triglyceride supplementation. We present the case of a 45-year-old woman who developed a symptomatic 15-cm pelvic lymphocyst one month after surgical staging for a mucinous borderline ovarian tumor. Following the placement of a percutaneous catheter drainage (PCD), the initial output was 300-400 mL/day of clear serous fluid. Notably, a delayed chylous conversion occurred on the 20th day of drainage, the fluid turned milky and biochemical analysis confirmed a triglyceride level of 493 mg/dL. Initiation of a modified high-protein, fat-restricted diet resulted in a rapid decrease in drainage volume to 30 mL/day within 24 hours, alongside a return to clear yellowish appearance. This study aims to report the clinical manifestations and to summarize current therapeutic options for patients with chylous leakage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.